Arrowhead Research reported 0 in Stock for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Agios Pharmaceuticals AGIO:US $ 14.7M 3.33M
Alnylam Pharmaceuticals ALNY:US $ 92.3M 8.26M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Arrowhead Research ARWR:US 0 0
Heron Therapeutics HRTX:US $ 41.9M 0.84M
Intercept Pharmaceuticals ICPT:US $ 9.03M 0.67M
Ligand Pharmaceuticals LGND:US $ 26.49M 13.06M
Merk MRK:US $ 6310M 182M
Nektar Therapeutics NKTR:US $ 15.29M 2.4M
Novartis NOVN:VX SF 7131M 5M
Sarepta Therapeutics SRPT:US $ 231.96M 11.84M
Ultragenyx Pharmaceutical RARE:US $ 13.05M 1.41M
Vertex Pharmaceuticals VRTX:US $ 280.78M 35.32M
YTE INCY:US $ 16.42M 0.59M